May 28, 2017

Patient-Centered Care Those Living with Atrial Fibrillation Endorsed by Medical Societies

Our latest EP Lab Digest article focuses on the new European Heart Rhythm Association consensus document about patient-centered care. To learn what is being recommended to doctors about treating patients with atrial fibrillation, see: New Consensus Document Embraces Patient-Centered Approach to Atrial Fibrillation

Dr. Mintu Turakhia on Avoiding Afib Strokes — Video from 2015 AF Patient Conference

In his talk about Avoiding Afib Strokes at the 2015 Get in Rhythm, Stay in Rhythm National Atrial Fibrillation Patient Conference, Dr. Mintu Turakhia of Stanford University discussed how our thinking about afib and stroke, and when to treat, has changed over the last couple of years. Access Dr. Turakhia’s talk at: Video: Avoiding Afib […]

Dr. Mintu Turakhia on Treating Atrial Fibrillation with Medications — Video From 2015 AF Patient Conference

In his talk about Treating Afib with Medications at the 2015 Get in Rhythm, Stay in Rhythm National Atrial Fibrillation Patient Conference, Dr. Mintu Turakhia of Stanford University covered many of the issues related to rate control and rhythm control medications and afib and heart failure. Access Dr. Turakhia’s talk at: Video: Treating Atrial Fibrillation […]

Afib patients from the US, Canada, and the Caribbean will be at the Atrial Fibrillation Patient Conference. Will you?

Are you joining us on March 28-29 in Dallas to learn from our world-renowned afib experts on how to get in rhythm and stay in rhythm? Afib patients are coming from all over to be here, and we hope you can join us, too. Learn more about the conference, and register, at: Afib Patients from […]

FDA gets request to approve Pradaxa reversal agent idarucizumab

Big news! Boehringer Ingelheim has submitted an application to the FDA requesting accelerated approval for idarucizumab, the reversal agent for Pradaxa (dabigatran). See: Boehringer Ingelheim Submits Biologics License Application to FDA for Idarucizumab*, Investigational Specific Reversal Agent for Pradaxa® Additionally, they have submitted for marketing approval by Health Canada and the European Medicines Agency (EMA). See: Boehringer […]

2015 Get in Rhythm, Stay in Rhythm Atrial Fibrillation Patient Conference

Plan to join us March 28-29, 2015, at the StopAfib.org National Atrial Fibrillation Patient Conference to hear our rock-star cast of afib experts share ways for you to get in rhythm and stay in rhythm. This is a not-to-be-missed event—take a look at who’s speaking! The conference will be held at the Hyatt Regency DFW […]

Antidote for Eliquis Shows Positive Results

Here’s more good news about the upcoming antidote for Eliquis – see: Positive Results for Factor Xa Inhibitor Antidote: ANNEXA-A

Deaths from atrial fibrillation high despite use of anticoagulants

Today, at the European Society of Cardiology Congress in Barcelona, it was reported that even though 80% of atrial fibrillation patients who should be on anticoagulants (according to their CHA2DS2-VASc score) are on anticoagulants, death rates at one year are still high. Most of those deaths are due to cardiovascular causes. The risk factors predicting […]

Top US Heart Centers and StopAfib.org Form Alliance to Improve Atrial Fibrillation Patient Care

Five top U.S. heart centers and StopAfib.org, a leading atrial fibrillation (afib) patient advocacy group, are partnering in the National Alliance of Integrated AFib Centers in order to improve the treatment of afib patients. Learn more at: Top U.S. Heart Treatment Centers, Patient Group, Form Alliance to Improve Irregular Heartbeat Care

Dr. Hugh Calkins Discusses New AHA/ACC/HRS Atrial Fibrillation Guidelines — Video

The new 2014 AHA/ACC/HRS Atrial Fibrillation Guidelines were just released at the American College of Cardiology annual conference. In this video interview, Dr. Hugh Calkins discusses what afib patients should know about the new afib guidelines. To watch the video, see: Dr. Hugh Calkins Discusses the New AHA/ACC/HRS Atrial Fibrillation Guidelines — Video Interview